Skip Navigation
 
Home | About CDC | Media Relations | A-Z Index | Contact Us
   
Centers for Disease Control & Prevention
CDC en Español 
Sexually Transmitted Diseases
Sexually Transmitted Diseases  >  Program Guidelines  >  Areas of Special Emphasis

Areas of Special EmphasisProgram Operations Guidelines for STD Prevention
Areas of Special Emphasis

Appendix SE-1

DSTD PROJECT AREA CORRECTIONAL HEALTH CARE ASSESSMENT

1. Project Area

2a. Person completing assessment from health department
Telephone

2b. Person assisting assessment completion from the facility
Telephone

3. Health Department FTE working on correctional health issues
Telephone

4. Date completed

Facility Profile

5. Name and Address of Facility.  Please specify type of facility (county, city, etc.)

6. Chief Medical Director
Telephone

7. Number of correctional health staff having attended CDC/state sponsored STD Prevention/Training Center Courses in 1996/1997.

_____ Comprehensive (2 weeks)

_____ Intensive (1 week)

_____ Part-Time Intensive (3 days)

_____ Advanced (1 week)

_____ Laboratory Methods (1-3 days)

_____ other (specify) ____________

8. What key person(s) at this facility represents correctional health care issues on the local HIV prevention community planning group? (If none or unknown, please state.)

9. Are health care services for inmates privatized?

Yes _____ No _____ Unknown _____

If yes, please specify the health services company having the service delivery contract.

10. Is the facility accredited by the National Commission on Correctional Health Care (NCCHC)?

Yes _____ No _____ Unknown _____

STD Testing and Treatment

11. Are all arrestees offered STD testing and are all women arrestees offered pregnancy testing? Please check only those STDs for which inmates are routinely offered testing. If information is unknown, please write "unknown" in the space provided.

    Males     Females
chlamydia    
gonorrhea    
syphilis    
hepatitis B    
pregnancy -  

12. Of the total number of arrestees, what percentage (%) receive STD testing within the specified time frames. The total for both males and females should add up to 100%.

    Males     Females
<24 hours    
24-48 hours    
3-7 days    
8-14 days    
>14 days    
not tested    
unknown    
Total    

13. If STD testing is not offered to all arrestees and pregnancy testing is not offered to all women arrestees, under what conditions are arrestees tested for the following STDs and pregnancy? Check all that apply.

 Males Symptoms Request Court Order Not Tested Unknown
chlamydia          
gonorrhea          
syphilis          
hepatitis B          

 Females Symptoms Request Court Order Not Tested Unknown
chlamydia          
gonorrhea          
syphilis          
hepatitis B          
pregnancy          

14. What percentage (%) of all arrestees are tested for the following STDs and pregnancy? If information is unknown, please write "unknown" in the space provided.

    Males     Females
chlamydia    
gonorrhea    
syphilis    
hepatitis B    
pregnancy   -  

15. Is a written protocol followed for STD screening?

Yes _____ No _____ Unknown

If yes, please specify:

_____ CDC Chlamydia Screening Guidelines

_____ Internal document

_____ Health department document

_____ other (specify)

16. Is a STAT RPR protocol routinely used to screen for syphilis?

Yes _____ No _____ Unknown _____

If no, what are the obstacles for implementing STAT RPR testing at intake?

Lack of:

_____ space

_____ money

_____ trained medical staff

_____ equipment

_____ time during intake medical exam

_____ unknown

_____ Other

17. Are chlamydia and gonorrhea screened using LCR or PCR testing?

Yes _____ No _____ Unknown _____

If no, what are the obstacles for implementing LCR or PCR testing for chlamydia and gonorrhea at intake?

Lack of:

_____ space

_____ money

_____ trained medical staff

_____ equipment

_____ time during intake medical exam

_____ unknown

_____ Other

18. Is a STAT pregnancy test protocol routinely used?

Yes _____ No _____ Unknown _____

If no, what are the obstacles for implementing STAT pregnancy testing for all women of child-bearing age?

Lack of:

_____ space

_____ money

_____ trained medical staff

_____ equipment

_____ time during intake medical exam

_____ unknown

_____ Other

19. Does this facility routinely offer HIV counseling and testing for inmates with diseases characterized by ulcers (e.g. syphilis, chancroid, genital herpes)?

Yes _____ No _____ Unknown _____

20. Are pap smears routinely offered to women inmates?

Yes _____ No _____ Unknown _____

22. Check the average turnaround time for laboratory results. Check only one response for each condition.

chlamydia ____<24 hours ____24-48 hours ____3-7 days ____>1 week

____no testing avail ____unknown

syphilis ____<24 hours ____24-48 hours ____3-7 days ____>1 week

____no testing avail ____unknown

gonorrhea ____<24 hours ____24-48 hours ____3-7 days ____>1 week

____no testing avail ____unknown

pregnancy ____<24 hours ____24-48 hours ____3-7 days ____>1 week

____no testing avail ____unknown

23. Specify the site(s) where laboratory STD diagnostic testing takes place.

  On-Site Off-Site (state public health lab) Off-Site (other) Unknown
chlamydia        
gonorrhea        
syphilis        
pregnancy        

24. Specify the site(s) where STD treatment is conducted.

  On-Site Off-Site Unknown
chlamydia      
gonorrhea      
syphilis      

25. Are inmates treated presumptively on-site for STD infection if symptomatic?

Yes _____ No _____ Unknown _____

26. Is a written protocol followed for STD treatment?

Yes _____ No _____ Unknown _____

If yes, please specify:

_____CDC/STD Treatment Guidelines

_____Internal document

_____Health department document

_____Other (specify)

27. If inmates are treated off-site for STD infection, are jail cases differentiated from other cases when morbidity

is reported from this off-site facility?

Yes _____ No _____ Unknown _____ Not Applicable_____

Inmate Population Profile

In the last two sections of this document, data will be requested to supplement and strengthen the information already given. For questions 28-39 use data from the last full month it is available. Please report all data from the same month/year. If information is unknown, please write "unknown" in the space provided.

28. Month/Year of data being reported in this section ____________

Males Females Total

    Males Females Total
29. Average # of admissions per day      
30. Average census per day      
31. Average length of stay (days):      
32. Average percent of arrestees released:

<24 hours

     
24-48 hours      
3-7 days      
8-14 days      
>14 days      
33. Average percentage of female arrestees charged with:

prostitution

     
drugs offenses      

STD Testing Volume During Last Full Month

For questions 34-39 please provide data from the last full month it is available. The month/year of data reported in this section should be the same as  the month/year in the previous section. If any of the information requested in this section is unknown, please write "unknown in the space provided.

34. Month/Year of data being reported in this section ___________

  Males Females Total
35. Number of chlamydia tests done      
a. Type of test(s) used. Check all that apply.

Culture

     
Gen-Probe      
PCR      
LCR      
EIA      
DFA      
Unknown      
Other (list)      
b. # of positive tests      
c. of those testing positive, provide the # of untreated inmates leaving facility requiring field follow-up      
d. of those requiring field follow-up, provide the # closed with C disposition (brought to treatment)      
e. of those requiring field follow-up, provide the # closed with E disposition (previously treated)      
f. total number of cases of chlamydia in the county      
36. Number of gonorrhea tests done      
a. Type of test(s) used. Check all that apply.

Culture

     
Gen-Probe      
PCR      
LCR      
Gram Stain      
Unknown      
Other (list)      
b. # of positive tests      
c. of those testing positive, provide the # of untreated inmates leaving facility requiring field follow-up      
d. of those requiring field follow-up, provide the # closed with C disposition (brought to treatment)      
e. of those requiring field follow-up, provide the # closed with E disposition (previously treated)      
f. total number of cases of gonorrhea in the county      
37. Number of serological tests for syphilis done      
a. Type of test(s) used. Check all that apply.

RPR

     
VDRL      
FTA      
TPPA      
Unknown      
Other (list)      
b. # of positive tests      
c. of those testing positive, provide the # of inmates tested, diagnosed, and treated for early syphilis while incarcerated      
d. of those testing positive, provide the # of inmates leaving facility requiring field follow-up      
e. of those requiring field follow-up, provide the # closed with C disposition (brought to treatment for early syphilis)      
f. of those requiring field follow-up, provide the # closed with E disposition (previously treated for early syphilis)      
g. of those requiring field follow-up, provide the # closed with F disposition (not infected)      
h. total number of cases of early syphilis in the county      
38. Number of HIV tests done      
a. # of positive tests      
39. Number of pregnancy tests done      
a. # of positive tests      

 40. What type of technical assistance would STD program managers like from the Division of STD Prevention at the CDC? Check all that apply.

_____site visit assessment

_____protocols of currently established and effective models of STD screening and treatment in jail settings

_____CDC STD guidelines for treatment and screening

_____consultation/mini-assessments

_____training (specify)

_____other (specify)

41. What percent (%) of the current resources at the state-level STD Prevention Office is directed toward STD prevention activities in correctional health care facilities?

Additional comments:

 



Page last modified: August 16, 2007
Page last reviewed: August 16, 2007 Historical Document

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention